Brief: Adicet Bio Q1 Basic EPS USD -0.31
06/05/2025 21:01
May 06 (Reuters) - Adicet Bio Q1 operating expenses USD 29.885 million. Q1 net income USD -28.214 million Q1 operating income USD -29.885 million
Recent news on ADICET Bio
See all newsNASDAQ RESUMED AT 09:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Brief: Adicet Bio Announces Positive Safety And Efficacy Data From Prula-Cel (Formerly Adi-001) Study In Patients With Systemic Lupus Erythematosus With Or Without Lupus Nephritis
Brief: Adicet Bio Announces FDA Clearance Of Ind Application For Adi-212
Adicet Bio, Inc. Reports Results For The Quarter Ended June 30: Earnings Summary